Skip to main content

Table 1 Distribution of characteristics in the two groups

From: Rapid molecular test (SeptiFast®) reduced time for adjustment of antibiotic treatment in comparison with conventional blood cultures in critically ill sepsis patients: a randomized controlled clinical trial (preliminary results)

 

Intervention group (n= 17)

Control group (n= 29)

Pvalue

Age (years)

63 (46 to 75)

66 (39 to 85)

0.340

Gender (female)

5 (30%)

10 (34%)

0.999

Hospital stay (mean, days)

32 (9 to 118)

31 (3 to 112)

0.632

APACHE II (mean)

17 (8 to 29)

17 (8 to 29)

0.730

Ejection fraction <40%

8 (47%)

17 (58%)

0.545

Receiving antibiotics prior to study

11 (65%)

11 (38%)

0.126

Septic shock

9 (53%)

16 (55%)

0.999

Patients with adjustment therapy based on SeptiFast®

6 (35%)

-

 

Patients with adjustment therapy based on blood culture

-

7 (21%)

 

Mean time (minutes) of adjustment therapy

580

3,007

0.004

Pathogens detected in SeptiFast®

P. aeruginosa (2), K. pneumonia/oxytoca (1), E. aerogenes/cloacae (1), S. marcescens (1), A. baumanii (1)

-

 

Pathogens detected in blood culture

-

S. aureus (4), K. pneumonia (2), M. morganii (1)

 

28-day mortality

9 (53%)

17 (59%)

0.765